MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KYMR has $1,742,812K in assets. $163,148K in debts. $357,011K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1046.98%
Quick Ratio
1046.98%
Cash Ratio
429.04%
Debt to Asset Ratio
9.36%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities, non-curre...
    • Marketable securities (note 4)
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
357,011
Marketable securities (note 4)
491,265
Prepaid expenses and other current assets
22,938
Total current assets
871,214
Marketable securities, non-current (note 4)
771,158
Property and equipment, net (note 6)
43,175
Right-of-use assets, operating leases
42,351
Other non-current assets
9,114
Restricted cash
5,800
Total assets
1,742,812
Accounts payable
4,015
Accrued expenses (note 8)
42,274
Deferred revenue
22,925
Operating lease liabilities
11,941
Finance lease liabilities
1,815
Other current liabilities
242
Total current liabilities
83,212
Deferred revenue, net of current portion
11,440
Operating lease liabilities, net of current portion
67,034
Finance lease liabilities, net of current portion
1,462
Total liabilities
163,148
Common stock, 0.0001 par value 150,000,000 shares authorized at december 31, 2025 and 2024, 81,323,532 and 64,890,193 shares issued and outstanding at december 31, 2025 and 2024, respectively
8
Additional paid-in capital
2,643,817
Accumulated deficit
-1,065,961
Accumulated other comprehensive income (loss)
1,800
Total stockholders' equity
1,579,664
Total liabilities and stockholders' equity
1,742,812
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities(note 4)$491,265K Cash and cashequivalents$357,011K Prepaid expenses andother current assets$22,938K Total current assets$871,214K Marketable securities,non-current (note 4)$771,158K Property and equipment,net (note 6)$43,175K Right-of-use assets,operating leases$42,351K Other non-currentassets$9,114K Restricted cash$5,800K Total assets$1,742,812K Total liabilities andstockholders' equity$1,742,812K Total stockholders'equity$1,579,664K Total liabilities$163,148K Accumulated deficit-$1,065,961K Additional paid-in capital$2,643,817K Total currentliabilities$83,212K Operating leaseliabilities, net of current...$67,034K Deferred revenue, net ofcurrent portion$11,440K Finance leaseliabilities, net of current...$1,462K Accumulated othercomprehensive income (loss)$1,800K Common stock, 0.0001par value...$8K Accrued expenses (note8)$42,274K Deferred revenue$22,925K Operating leaseliabilities$11,941K Accounts payable$4,015K Finance leaseliabilities$1,815K Other currentliabilities$242K

Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics, Inc. (KYMR)